NEW YORK — Patients with primary malignant melanoma are at a higher risk for tumor recurrence if they have mutations in two or more cancer-related genes, according to study results presented at HemOnc Today Melanoma and Cutaneous Malignancies
Scientific Publications
Experts debate role of completion lymphadenectomy for node-positive melanoma
NEW YORK — Two speakers debated whether completion lymphadenectomy is still standard of care for patients with sentinel lymph-node positive melanoma at HemOnc Today Melanoma and Cutaneous Malignancies.
Biomarker for Class 1 Uveal Melanoma Correlates with Metastatic Disease
A new biomarker measurement might improve the accuracy of prognostic testing and precision medicine in uveal melanoma, according to a study published in Clinical Cancer Research.1
Longer surgical interval shortens RFS when residual melanoma is present
NEW YORK — Longer surgical interval following initial biopsy may worsen RFS outcomes in patients with residual melanoma, according to a retrospective review presented at HemOnc Today Melanoma and Cutaneous Malignancies.